Micronutrients and lifestyles in Taiwanese patients with stage 3 to 5 chronic kidney disease

Shou Shan Chiang, Cheng Wei Tai, Chi Jung Chung, Horng Sheng Shiue, Jin Bor Chen, Chien-Tien Su, Yu-Mei Hsueh

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: Lycopene is an antioxidant that reduces oxidative stress. Analgesics are commonly used and may impair kidney function. However, the associations among plasma lycopene, analgesic use, and chronic kidney disease (CKD) are unknown. A hospital-based, case-control study was conducted to determine the association among plasma lycopene, analgesic use, and CKD. Methods: Two hundred one patients with CKD and 313 controls were recruited, and CKD was defined as an estimated glomerular filtration rate 2, as calculated by the Modification of Diet in Renal Disease formula. Plasma antioxidants were measured by high-performance liquid chromatography. Results: This study showed that the higher the plasma lycopene was, the lower the CKD risk. Specifically, in subjects with a plasma lycopene level ≥17.97 or 7.72-17.97 μg/dL, the adjusted odds ratio of CKD was 0.32 (95% confidence interval 0.18-0.58) or 0.49 (95% confidence interval 0.29-0.83), respectively, compared with subjects with a plasma lycopene level

Original languageEnglish
Pages (from-to)276-282
Number of pages7
JournalNutrition
Volume26
Issue number3
DOIs
Publication statusPublished - Mar 2010

Fingerprint

Micronutrients
Chronic Renal Insufficiency
Life Style
Analgesics
Antioxidants
Confidence Intervals
Diet Therapy
Kidney
Glomerular Filtration Rate
lycopene
Case-Control Studies
Oxidative Stress
Odds Ratio
High Pressure Liquid Chromatography

Keywords

  • Analgesics
  • Chronic kidney disease
  • Lycopene
  • Micronutrients

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Micronutrients and lifestyles in Taiwanese patients with stage 3 to 5 chronic kidney disease. / Chiang, Shou Shan; Tai, Cheng Wei; Chung, Chi Jung; Shiue, Horng Sheng; Chen, Jin Bor; Su, Chien-Tien; Hsueh, Yu-Mei.

In: Nutrition, Vol. 26, No. 3, 03.2010, p. 276-282.

Research output: Contribution to journalArticle

Chiang, Shou Shan ; Tai, Cheng Wei ; Chung, Chi Jung ; Shiue, Horng Sheng ; Chen, Jin Bor ; Su, Chien-Tien ; Hsueh, Yu-Mei. / Micronutrients and lifestyles in Taiwanese patients with stage 3 to 5 chronic kidney disease. In: Nutrition. 2010 ; Vol. 26, No. 3. pp. 276-282.
@article{e9823ba0f1f64b19897680b186b94cd6,
title = "Micronutrients and lifestyles in Taiwanese patients with stage 3 to 5 chronic kidney disease",
abstract = "Objective: Lycopene is an antioxidant that reduces oxidative stress. Analgesics are commonly used and may impair kidney function. However, the associations among plasma lycopene, analgesic use, and chronic kidney disease (CKD) are unknown. A hospital-based, case-control study was conducted to determine the association among plasma lycopene, analgesic use, and CKD. Methods: Two hundred one patients with CKD and 313 controls were recruited, and CKD was defined as an estimated glomerular filtration rate 2, as calculated by the Modification of Diet in Renal Disease formula. Plasma antioxidants were measured by high-performance liquid chromatography. Results: This study showed that the higher the plasma lycopene was, the lower the CKD risk. Specifically, in subjects with a plasma lycopene level ≥17.97 or 7.72-17.97 μg/dL, the adjusted odds ratio of CKD was 0.32 (95{\%} confidence interval 0.18-0.58) or 0.49 (95{\%} confidence interval 0.29-0.83), respectively, compared with subjects with a plasma lycopene level",
keywords = "Analgesics, Chronic kidney disease, Lycopene, Micronutrients",
author = "Chiang, {Shou Shan} and Tai, {Cheng Wei} and Chung, {Chi Jung} and Shiue, {Horng Sheng} and Chen, {Jin Bor} and Chien-Tien Su and Yu-Mei Hsueh",
year = "2010",
month = "3",
doi = "10.1016/j.nut.2009.04.021",
language = "English",
volume = "26",
pages = "276--282",
journal = "Nutrition",
issn = "0899-9007",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Micronutrients and lifestyles in Taiwanese patients with stage 3 to 5 chronic kidney disease

AU - Chiang, Shou Shan

AU - Tai, Cheng Wei

AU - Chung, Chi Jung

AU - Shiue, Horng Sheng

AU - Chen, Jin Bor

AU - Su, Chien-Tien

AU - Hsueh, Yu-Mei

PY - 2010/3

Y1 - 2010/3

N2 - Objective: Lycopene is an antioxidant that reduces oxidative stress. Analgesics are commonly used and may impair kidney function. However, the associations among plasma lycopene, analgesic use, and chronic kidney disease (CKD) are unknown. A hospital-based, case-control study was conducted to determine the association among plasma lycopene, analgesic use, and CKD. Methods: Two hundred one patients with CKD and 313 controls were recruited, and CKD was defined as an estimated glomerular filtration rate 2, as calculated by the Modification of Diet in Renal Disease formula. Plasma antioxidants were measured by high-performance liquid chromatography. Results: This study showed that the higher the plasma lycopene was, the lower the CKD risk. Specifically, in subjects with a plasma lycopene level ≥17.97 or 7.72-17.97 μg/dL, the adjusted odds ratio of CKD was 0.32 (95% confidence interval 0.18-0.58) or 0.49 (95% confidence interval 0.29-0.83), respectively, compared with subjects with a plasma lycopene level

AB - Objective: Lycopene is an antioxidant that reduces oxidative stress. Analgesics are commonly used and may impair kidney function. However, the associations among plasma lycopene, analgesic use, and chronic kidney disease (CKD) are unknown. A hospital-based, case-control study was conducted to determine the association among plasma lycopene, analgesic use, and CKD. Methods: Two hundred one patients with CKD and 313 controls were recruited, and CKD was defined as an estimated glomerular filtration rate 2, as calculated by the Modification of Diet in Renal Disease formula. Plasma antioxidants were measured by high-performance liquid chromatography. Results: This study showed that the higher the plasma lycopene was, the lower the CKD risk. Specifically, in subjects with a plasma lycopene level ≥17.97 or 7.72-17.97 μg/dL, the adjusted odds ratio of CKD was 0.32 (95% confidence interval 0.18-0.58) or 0.49 (95% confidence interval 0.29-0.83), respectively, compared with subjects with a plasma lycopene level

KW - Analgesics

KW - Chronic kidney disease

KW - Lycopene

KW - Micronutrients

UR - http://www.scopus.com/inward/record.url?scp=75949092997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75949092997&partnerID=8YFLogxK

U2 - 10.1016/j.nut.2009.04.021

DO - 10.1016/j.nut.2009.04.021

M3 - Article

VL - 26

SP - 276

EP - 282

JO - Nutrition

JF - Nutrition

SN - 0899-9007

IS - 3

ER -